Terns Pharmaceuticals, Inc. (TERN)
52.88
+2.88
(+5.76%)
USD |
NASDAQ |
Mar 25, 16:00
53.09
+0.21
(+0.40%)
After-Hours: 20:00
Terns Pharmaceuticals Cash from Financing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 588.67M |
| BioMarin Pharmaceutical, Inc. | 3.157M |
| ADMA Biologics, Inc. | -9.118M |
| Arcellx, Inc. | 1.634M |
| Corcept Therapeutics, Inc. | -31.22M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.77M |
| Cash from Investing (Quarterly) | 24.50M |
| Free Cash Flow | -77.99M |
| Free Cash Flow Per Share (Quarterly) | -0.2156 |
| Free Cash Flow to Equity (Quarterly) | -19.67M |
| Free Cash Flow to Firm (Quarterly) | -19.77M |
| Free Cash Flow Yield | -1.61% |